Study brain tumor testing with MRI and extra tissue samples
Part of Cancer clinical trials.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 89
- Have a brain tumor called a glioma that is grade II, III, or IV (confirmed or suspected by imaging/doctor review)
- Be newly diagnosed with no prior treatment (except a prior biopsy)
- Plan to have surgery to remove and biopsy the tumor, with enough tissue for at least two biopsy samples
- Be able to do MRI: lie flat for up to 80 minutes and stay still; you must be able to read and write English
- Have signed the consent form (you or your legally authorized representative)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special PET and MRI scans to map the activity and oxygen levels of brain tumors (gliomas). The results help doctors plan treatment that is more tailored to each patient.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This study uses MRI scans to look for signs of brain tumour activity without needing additional surgery. If you are already having brain surgery, the researchers will compare the MRI images with the tumour tissue to better understand the cancer.
This study uses special MRI scans to better “characterize” (study) gliomas, a type of brain tumor, using information from your brain tissue. You may be eligible if you’re an adult with a suspected or confirmed glioma and you already need a biopsy or surgery.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.